Gland Pharma Ltd.

Financial

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Operational Metrics
API Sector
US DMF Filings	68.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	366.0 .	46.0 .	n/a
Number of ANDA's Approved By USFDA	312.0 .	33.0 .	n/a
Unclassified
R&D as a % of Total Sales	4.3 %	4.4 %	0.83 %
API Capacity	11000.0 Kg/Year	n/a	n/a
Financials
5 yr Average ROE	14.74 %	20.61 %	25.05 %
5yr average Equity Multiplier	1.13	1.17	2.22
5yr Average Asset Turnover Ratio	0.53	0.72	1.05
5yr Avg Net Profit Margin	24.17 %	24.8 %	10.9 %
Price to Book	2.77	5.64	6.3
P/E	34.6	27.85	44.15
5yr Avg Cash Conversion Cycle	72.51 Days	79.85 Days	26.94 Days
Inventory Days	117.52 Days	64.55 Days	66.86 Days
Days Receivable	78.29 Days	100.92 Days	128.09 Days
Days Payable	103.04 Days	74.04 Days	163.91 Days
5yr Average Interest Coverage Ratio	205.64	579.71	13.1
5yr Avg ROCE	19.61 %	25.27 %	27.25 %
5yr Avg Operating Profit Margin	32.0 %	30.87 %	18.45 %
5 yr average Debt to Equity	0.01	0.01	0.51
5yr CAGR Net Profit	-0.01 %	16.28 %	14.26 %
5yr Average Return on Assets	13.18 %	17.7 %	11.52 %
Shareholdings
Promoter Holding	51.83 %	70.56 %	72.51 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.17 %	1.67 %	-2.97 %
Change in Mutual Fund Holding (3 Yrs)	19.94 %	0.55 %	2.36 %

Business

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Injectables 0 Branded Generic 0 Generic 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up Injectables 0 API 0 Anti-bacterials 0 Formulations 75.0 Domestic 0 Pharmaceutical 0 Proton pump inhibitors 0 International 0 Anti-fungals 0 Cardiovascular 0 Muscle Relaxants 0 Branded Generics 25.0 CMO 0	Product Wise Break-Up Injectables 0 Active Pharmaceutical Ingredient (API) 5.0 Anti-bacterials 0 Generic 0 Domestic Pharmaceuticals 50.0 Pharmaceutical 0 Proton pump inhibitors 0 International 15.0 Anti-fungals 0 Cardiovascular 0 Muscle Relaxants 0 Branded Generic 0 CMO 30.0
Location Wise Break-Up	Location Wise Break-Up USA 52.69 Europe 19.12 India 4.06 Canada, Australia & New Zealand 3.32 Australia 0 Canada 0 Africa 0 LATAM 0 South America 0 North America 0 Asia 0 Rest of the World 0 Others 20.81	Location Wise Break-Up Australia 0 India 0 Canada 0 Rest of the World 0 Europe 0 Africa 2.0 Latin America 80.0 USA 18.0 South America 0 Canada, Australia & New Zealand 0 North America 0 Asia 0	Location Wise Break-Up Australia 0.53 India 89.07 Canada 0 Rest of the World 0 Europe 3.67 Africa 0.72 LATAM 0 USA 0 South America 0.23 Canada, Australia & New Zealand 0 North America 1.27 Asia Pacific 4.5 Others 0.01
Distribution Channel	Distribution Channel B2B 98.0 B2C 2.0 Tender Business 0 Pharmacy Sales 0 Distributors 0	Distribution Channel Distribution 55.0 B2C 0 B2B 0 Tender Business 20.0 Pharmacy and Dietary 25.0	-

Gland Pharma Ltd.

SIGN UP FOR FREE